Bacterial community structure alterations within the colorectal cancer gut microbiome.
Associations
Cancer
Colorectal
Metagenomics
Microbiome
Networks
Oral
Pathogens
Journal
BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981
Informations de publication
Date de publication:
31 03 2021
31 03 2021
Historique:
received:
23
12
2020
accepted:
16
03
2021
entrez:
1
4
2021
pubmed:
2
4
2021
medline:
15
12
2021
Statut:
epublish
Résumé
Colorectal cancer is a leading cause of cancer-related deaths worldwide. The human gut microbiome has become an active area of research for understanding the initiation, progression, and treatment of colorectal cancer. Despite multiple studies having found significant alterations in the carriage of specific bacteria within the gut microbiome of colorectal cancer patients, no single bacterium has been unequivocally connected to all cases. Whether alterations in species carriages are the cause or outcome of cancer formation is still unclear, but what is clear is that focus should be placed on understanding changes to the bacterial community structure within the cancer-associated gut microbiome. By applying a novel set of analyses on 252 previously published whole-genome shotgun sequenced fecal samples from healthy and late-stage colorectal cancer subjects, we identify taxonomic, functional, and structural changes within the cancer-associated human gut microbiome. Bacterial association networks constructed from these data exhibited widespread differences in the underlying bacterial community structure between healthy and colorectal cancer associated gut microbiomes. Within the cancer-associated ecosystem, bacterial species were found to form associations with other species that are taxonomically and functionally dissimilar to themselves, as well as form modules functionally geared towards potential changes in the tumor-associated ecosystem. Bacterial community profiling of these samples revealed a significant increase in species diversity within the cancer-associated gut microbiome, and an elevated relative abundance of species classified as originating from the oral microbiome including, but not limited to, Fusobacterium nucleatum, Peptostreptococcus stomatis, Gemella morbillorum, and Parvimonas micra. Differential abundance analyses of community functional capabilities revealed an elevation in functions linked to virulence factors and peptide degradation, and a reduction in functions involved in amino-acid biosynthesis within the colorectal cancer gut microbiome. We utilize whole-genome shotgun sequenced fecal samples provided from a large cohort of late-stage colorectal cancer and healthy subjects to identify a number of potentially important taxonomic, functional, and structural alterations occurring within the colorectal cancer associated gut microbiome. Our analyses indicate that the cancer-associated ecosystem influences bacterial partner selection in the native microbiota, and we highlight specific oral bacteria and their associations as potentially relevant towards aiding tumor progression.
Sections du résumé
BACKGROUND
Colorectal cancer is a leading cause of cancer-related deaths worldwide. The human gut microbiome has become an active area of research for understanding the initiation, progression, and treatment of colorectal cancer. Despite multiple studies having found significant alterations in the carriage of specific bacteria within the gut microbiome of colorectal cancer patients, no single bacterium has been unequivocally connected to all cases. Whether alterations in species carriages are the cause or outcome of cancer formation is still unclear, but what is clear is that focus should be placed on understanding changes to the bacterial community structure within the cancer-associated gut microbiome.
RESULTS
By applying a novel set of analyses on 252 previously published whole-genome shotgun sequenced fecal samples from healthy and late-stage colorectal cancer subjects, we identify taxonomic, functional, and structural changes within the cancer-associated human gut microbiome. Bacterial association networks constructed from these data exhibited widespread differences in the underlying bacterial community structure between healthy and colorectal cancer associated gut microbiomes. Within the cancer-associated ecosystem, bacterial species were found to form associations with other species that are taxonomically and functionally dissimilar to themselves, as well as form modules functionally geared towards potential changes in the tumor-associated ecosystem. Bacterial community profiling of these samples revealed a significant increase in species diversity within the cancer-associated gut microbiome, and an elevated relative abundance of species classified as originating from the oral microbiome including, but not limited to, Fusobacterium nucleatum, Peptostreptococcus stomatis, Gemella morbillorum, and Parvimonas micra. Differential abundance analyses of community functional capabilities revealed an elevation in functions linked to virulence factors and peptide degradation, and a reduction in functions involved in amino-acid biosynthesis within the colorectal cancer gut microbiome.
CONCLUSIONS
We utilize whole-genome shotgun sequenced fecal samples provided from a large cohort of late-stage colorectal cancer and healthy subjects to identify a number of potentially important taxonomic, functional, and structural alterations occurring within the colorectal cancer associated gut microbiome. Our analyses indicate that the cancer-associated ecosystem influences bacterial partner selection in the native microbiota, and we highlight specific oral bacteria and their associations as potentially relevant towards aiding tumor progression.
Identifiants
pubmed: 33789570
doi: 10.1186/s12866-021-02153-x
pii: 10.1186/s12866-021-02153-x
pmc: PMC8011136
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
98Références
Anaerobe. 2019 Feb;55:54-60
pubmed: 30359695
Bioinformatics. 2014 May 1;30(9):1236-40
pubmed: 24451626
Phys Rev E Stat Nonlin Soft Matter Phys. 2004 Dec;70(6 Pt 2):066111
pubmed: 15697438
Front Microbiol. 2018 Aug 14;9:1835
pubmed: 30154767
Sci Rep. 2021 Feb 2;11(1):2828
pubmed: 33531651
Cancer Res. 2015 Feb 1;75(3):544-53
pubmed: 25644265
Nat Commun. 2015 Mar 11;6:6528
pubmed: 25758642
Cell Metab. 2017 May 2;25(5):1054-1062.e5
pubmed: 28467925
EMBO Rep. 2019 Apr;20(4):
pubmed: 30833345
Eur J Biochem. 1977 Dec;81(3):599-607
pubmed: 598383
Nat Rev Cancer. 2018 Oct;18(10):619-633
pubmed: 30097614
Microbes Infect. 2015 Jul;17(7):517-30
pubmed: 25841800
PLoS Comput Biol. 2012;8(6):e1002358
pubmed: 22719234
Nucleic Acids Res. 2019 Jan 8;47(D1):D427-D432
pubmed: 30357350
J Gen Physiol. 1927 Mar 7;8(6):519-30
pubmed: 19872213
Nat Rev Immunol. 2010 Oct;10(10):735-44
pubmed: 20865020
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819867354
pubmed: 31370775
Int J Syst Bacteriol. 1999 Oct;49 Pt 4:1375-9
pubmed: 10555315
J Clin Microbiol. 2002 Oct;40(10):3871-3
pubmed: 12354905
J Infect Dis. 2011 Feb 1;203(3):306-11
pubmed: 21208921
Gut Microbes. 2016 Nov;7(6):455-458
pubmed: 27723427
JAMA. 2008 Dec 17;300(23):2765-78
pubmed: 19088354
Nat Med. 2019 Apr;25(4):667-678
pubmed: 30936548
NPJ Biofilms Microbiomes. 2017 Nov 29;3:34
pubmed: 29214046
Gastroenterology. 2017 Mar;152(4):851-866.e24
pubmed: 27876571
ISME J. 2021 Apr;15(4):939-948
pubmed: 33219299
Nucleic Acids Res. 2014 Jan;42(Database issue):D643-8
pubmed: 24293649
Microbiome. 2018 Apr 11;6(1):70
pubmed: 29642940
Nucleic Acids Res. 2001 Jan 1;29(1):41-3
pubmed: 11125044
Nat Rev Cancer. 2017 Oct;17(10):577-593
pubmed: 28912578
Curr Opin Clin Nutr Metab Care. 2015 Jan;18(1):71-7
pubmed: 25474014
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Front Cell Infect Microbiol. 2012 Jun 22;2:86
pubmed: 22919677
Biostatistics. 2008 Jul;9(3):432-41
pubmed: 18079126
Nat Rev Cancer. 2002 Jan;2(1):38-47
pubmed: 11902584
Oncogenesis. 2016 Jan 25;5:e189
pubmed: 26807644
Front Microbiol. 2017 Nov 15;8:2224
pubmed: 29187837
Oral Implantol (Rome). 2017 Nov 30;10(3):229-233
pubmed: 29285324
Periodontol 2000. 2002;28:12-55
pubmed: 12013340
Microbiome. 2013 May 15;1(1):16
pubmed: 24450771
J Bacteriol. 2009 Dec;191(23):7157-64
pubmed: 19783625
ISME J. 2011 Sep;5(9):1414-25
pubmed: 21430787
Front Microbiol. 2019 Apr 24;10:826
pubmed: 31068913
Int J Cancer. 2017 Feb 1;140(3):646-652
pubmed: 27778343
MD Comput. 1997 Jul-Aug;14(4):306-17
pubmed: 9230594
Nutrients. 2019 Jan 14;11(1):
pubmed: 30646512
PLoS Comput Biol. 2015 May 07;11(5):e1004226
pubmed: 25950956
Genome Med. 2016 Apr 06;8(1):37
pubmed: 27056827
Cell. 1990 Jun 1;61(5):759-67
pubmed: 2188735
Nat Rev Microbiol. 2010 Jan;8(1):15-25
pubmed: 19946288
Nature. 2016 Jul 06;535(7610):65-74
pubmed: 27383981
mSystems. 2018 Dec 4;3(6):
pubmed: 30534599
J Natl Cancer Inst. 2013 Dec 18;105(24):1907-11
pubmed: 24316595
Biochem Biophys Res Commun. 2016 Jan 22;469(4):967-77
pubmed: 26718401
PeerJ. 2018 Apr 18;6:e4652
pubmed: 29682424
BMC Microbiol. 2010 Mar 01;10:66
pubmed: 20193074
PeerJ. 2017 Oct 4;5:e3889
pubmed: 29018622
Science. 2018 Jan 5;359(6371):104-108
pubmed: 29302014
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Science. 2018 Jan 5;359(6371):97-103
pubmed: 29097493
Gut. 2017 Apr;66(4):633-643
pubmed: 26992426
Nature. 2012 Sep 13;489(7415):220-30
pubmed: 22972295
J Mach Learn Res. 2012 Apr;13:1059-1062
pubmed: 26834510
Oral Microbiol Immunol. 2000 Aug;15(4):269-72
pubmed: 11154414
Nat Rev Microbiol. 2012 Jun 25;10(8):575-82
pubmed: 22728587
BMC Bioinformatics. 2007 Jan 25;8:25
pubmed: 17254353
Nature. 2013 May 30;497(7451):633-7
pubmed: 23665962
Nat Prod Rep. 2018 May 1;35(5):455-488
pubmed: 29799048
PLoS Biol. 2016 Aug 19;14(8):e1002533
pubmed: 27541692
Cell. 2017 Jul 27;170(3):548-563.e16
pubmed: 28753429
Nutrients. 2015 Apr 16;7(4):2930-46
pubmed: 25894657
Clin Transl Gastroenterol. 2016 Nov 3;7(11):e200
pubmed: 27811909
Ann Oncol. 2011 Sep;22(9):1958-1972
pubmed: 21307158
Appl Environ Microbiol. 2003 Nov;69(11):6354-60
pubmed: 14602586
Adv Neural Inf Process Syst. 2010 Dec 31;24(2):1432-1440
pubmed: 25152607
Nat Med. 2019 Jun;25(6):968-976
pubmed: 31171880
Eur J Immunol. 2015 Jan;45(1):17-31
pubmed: 25328099
BMC Bioinformatics. 2010 Mar 08;11:119
pubmed: 20211023
J Appl Microbiol. 2021 Jul;131(1):435-448
pubmed: 33245828
Medicine (Baltimore). 2018 Sep;97(37):e12244
pubmed: 30212957
Cell. 2016 Jun 2;165(6):1332-1345
pubmed: 27259147
Nat Rev Microbiol. 2010 Apr;8(4):290-5
pubmed: 20234377
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4283-8
pubmed: 18337506
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
Epidemiol Rev. 2017 Jan 1;39(1):49-58
pubmed: 28449041
CA Cancer J Clin. 2020 May;70(3):145-164
pubmed: 32133645
Nat Rev Immunol. 2009 May;9(5):313-23
pubmed: 19343057
Anaerobe. 2020 Apr;62:102100
pubmed: 31521732
Trends Mol Med. 2017 Jan;23(1):18-30
pubmed: 27986421
Nucleic Acids Res. 2016 Jan 4;44(D1):D733-45
pubmed: 26553804
Gastroenterology. 2010 Jun;138(6):2044-58
pubmed: 20420945
PLoS One. 2011;6(12):e27992
pubmed: 22162995
Gut. 2018 Aug;67(8):1454-1463
pubmed: 28988196
World J Gastroenterol. 2011 Mar 28;17(12):1519-28
pubmed: 21472114
Proc Natl Acad Sci U S A. 2018 Dec 18;115(51):E11951-E11960
pubmed: 30510004
J Biol Chem. 2007 Aug 24;282(34):25000-9
pubmed: 17588948